Yes, liquid biopsies are a non-invasive method to detect DNA changes in cancer. They involve analyzing circulating tumor DNA (ctDNA) in the blood, offering a means to monitor tumor dynamics and response to treatment. Liquid biopsies are particularly useful for detecting minimal residual disease and for identifying genetic mutations that may not be captured through traditional biopsy methods.
